Abstract
Objective
To study the efficacy of the aromatase inhibitor letrozole in controlled ovarian hyperstimulation (COH).
Material and methods
In this prospective simply randomized clinical trial, one hundred forty patients with unexplained infertility undergoing intrauterine insemination (IUI) therapy were randomized to receive either letrozole or clomiphene citrate (CC)-gonadotropin. The patients were selected among patients referred to one university hospital and one private infertility clinic. A letrozole dose of 5 mg/day (n = 70) was given on days 3–7 of the menstrual cycles. Clomiphen citrate a dose of 100 mg/day was given like letrozole but combined with human menopausal gonadotropin (hMG) dose of 75 IU/ml administered every day starting on day 6. Ovulation was triggered with urinary hCG (10,000 IU) when the leading follicle(s) reached 18 mm in diameter. A single IUI was performed 36 hours later. The luteal phase was supplemented with micronized progesterone vaginally. Ovarian stimulation response (E2 levels and number of follicles) was primary outcome.
Results
There were no differences in demographic characteristics between groups. The number of mature follicles (1.8 ± 0.7 vs. 2.46 ± 2.3; P = 0.042) and serum E2 level on the day of hCG (310 ± 135.4 vs. 1,670.7 ± 1021.8 pg/ml, respectively; P < 0.0001) were significantly lower in letrozole group. A significantly higher endometrial thickness was observed at the time of hCG administration in patients that received letrozole (9.7 ± 1.6 mm vs. 7.8 ± 2 mm; P < 0.001).Clinical pregnancy rates also were significantly higher in letrozole group (32.8% vs. 14.3%, respectively; P < 0.01).
Conclusion
The aromatase inhibitor letrozole appears to constitute a good alternative to CC-gonadotropin in patients with unexplained infertility undergoing COH cycles combined with IUI therapy.
Similar content being viewed by others
References
Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;25(1):CD002249.
Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996;11(12):2623–8.
Gorlitsky GA, Kase NG, Speroff L. Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol 1978;51(3):265–9.
Garcia J, Jones GS, Wentz AC. The use of clomiphene citrate. Fertil Steril 1977;28(7):707–17.
Hammond MG. Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril 1984;42(4):499–509.
Gysler M, March CM, Mishell DR, Bailey EJ. A decades experience with an individualized clomiphene treatment regimen including its effects on the postcoital teat. Fertil Steril 1982;37:161–7.
Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril 1991;56(3):465–8.
Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990;5(6):670–4.
Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol. 1989;73(2):187–90.
Opsahl MS, Robins ED, O’Connor DM, Scott RT, Fritz MA. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996;66(4):533–9.
Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75(2):305–9.
Casper RF. Letrozole: ovulation or superovulation? Fertil Steril 2003 Dec;80(6):1335–7.
Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004;22(1):61–78.
Kilic-Okman T, Kucuk M, Altaner S. Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat. Fertil Steril 2003;80(6):1330–2.
Ivoson T, Smith I, Ahern J, Smithers D, Trunel P, Dowseh M. Phase I study of the oral nonsteroidal aromatase inhibiter COS 20267 in post menopausal patients with advanced breast cancer. Cancer Res 1993;53:266–70.
Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;18(8):1588–97.
Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril 2006;85(6):1774–7.
Netter J. Applied linear statistical models. Richard D. Irwin Inc., Homewood, IL, USA; 1974. p. 833.
Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23(19):4347–53.
Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192(2):381–6.
Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin–letrozole in comparison with metformin–clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21(6):1432–5.
Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002;78(2):280–5.
Acknowledgment
This research has been supported by Tehran University of Medical Sciences and we would like to thank the staff of Vali-e Asr infertility Research Center and The Royan Institute for their cooperation throughout the stages of the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sh. Tehrani nejad, E., Abediasl, Z., Rashidi, B.H. et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. J Assist Reprod Genet 25, 187–190 (2008). https://doi.org/10.1007/s10815-008-9209-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-008-9209-2